Last reviewed · How we verify

NCT04598854

Intravascular Laser Irradiation of Blood for Osteoarthritis of Knee

Completed NA Last updated 18 March 2025
What this trial tests

NA trial testing Intravascular laser irradiation of blood in Osteoarthritis, Knee in 17 participants. Completed in 30 July 2023.

Timeline
28 October 2020
Primary endpoint
30 May 2023
30 July 2023

Quick facts

Lead sponsorTri-Service General Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment17
Start date28 October 2020
Primary completion30 May 2023
Estimated completion30 July 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Tri-Service General Hospital

Who can join

Adults 50 to 75, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is designed through randomization, control, and double-blind trial to explore the clinical effectiveness of intravenous laser irradiation of blood for knee degenerative arthritis; and to explore the changes in body's balance function. Furthermore to establish a new way of clinical rehabilitation therapy. The research will further study the special biomarker to investigate the mechanism of low-energy intravenous laser therapy for osteoarthritis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Effect of Intravascular Laser Irradiation of Blood on Serum Biomarkers and Clinical Outcome in Knee Osteoarthritis Patients: A Double-Blind Randomized Control Trial.
    Su YC, Shen YP, Chang CY, Pan KT, et al · · 2024 · cited 2× · PMID 39769371 · DOI 10.3390/ijms252413608

Verify or expand the search:

Other trials of Intravascular laser irradiation of blood

Trials testing the same drug.

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other Tri-Service General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04598854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing